New guidance on peri-operative care of transgender and gender-diverse individuals is today published in Anaesthesia (the journal of the Association of Anaesthetists) to guide best practice to ensure the safety and dignity of transgender and gender-diverse people in the peri-operative period.
Pfizer and Astellas seek updated EMA approval for Padcev with Keytruda – Pharmaceutical Technology
Share this article Padcev was originally approved for advanced and metastatic urothelial cancer patients in April 2022. Image credit: Shutterstock/Oleksandr Drypsiak. Pfizer and Astellas Pharma